• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种通过跨膜结构域起作用的新型N-甲基-D-天冬氨酸受体正变构调节剂。

A novel NMDA receptor positive allosteric modulator that acts via the transmembrane domain.

作者信息

Wang Tzu-Ming, Brown Brandon M, Deng Lunbin, Sellers Benjamin D, Lupardus Patrick J, Wallweber Heidi J A, Gustafson Amy, Wong Evera, Volgraf Matthew, Schwarz Jacob B, Hackos David H, Hanson Jesse E

机构信息

Department of Neuroscience, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, United States.

Department of Discovery Chemistry, Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, United States.

出版信息

Neuropharmacology. 2017 Jul 15;121:204-218. doi: 10.1016/j.neuropharm.2017.04.041. Epub 2017 Apr 27.

DOI:10.1016/j.neuropharm.2017.04.041
PMID:28457974
Abstract

Ionotropic glutamate receptors (iGluRs) mediate fast excitatory neurotransmission and are key nervous system drug targets. While diverse pharmacological tools have yielded insight into iGluR extracellular domain function, less is known about molecular mechanisms underlying the ion conduction gating process within the transmembrane domain (TMD). We have discovered a novel NMDAR positive allosteric modulator (PAM), GNE-9278, with a unique binding site on the extracellular surface of the TMD. Mutation of a single residue near the Lurcher motif on GluN1 M3 can convert GNE-9278 modulation from positive to negative, and replacing three AMPAR pre-M1 residues with corresponding NMDAR residues can confer GNE-9278 sensitivity to AMPARs. Modulation by GNE-9278 is state-dependent and significantly alters extracellular domain pharmacology. The unique properties and structural determinants of GNE-9278 reveal new modulatory potential of the iGluR TMD.

摘要

离子型谷氨酸受体(iGluRs)介导快速兴奋性神经传递,是关键的神经系统药物靶点。虽然多种药理学工具已让人们深入了解iGluR细胞外结构域的功能,但对于跨膜结构域(TMD)内离子传导门控过程的分子机制却知之甚少。我们发现了一种新型NMDAR正变构调节剂(PAM)GNE-9278,它在TMD的细胞外表面有一个独特的结合位点。GluN1 M3上靠近Lurcher模体的单个残基发生突变,可使GNE-9278的调节作用从正向变为负向,用相应的NMDAR残基替换三个AMPAR M1前体残基可使AMPAR对GNE-9278敏感。GNE-9278的调节作用具有状态依赖性,并显著改变细胞外结构域药理学。GNE-9278的独特性质和结构决定因素揭示了iGluR TMD新的调节潜力。

相似文献

1
A novel NMDA receptor positive allosteric modulator that acts via the transmembrane domain.一种通过跨膜结构域起作用的新型N-甲基-D-天冬氨酸受体正变构调节剂。
Neuropharmacology. 2017 Jul 15;121:204-218. doi: 10.1016/j.neuropharm.2017.04.041. Epub 2017 Apr 27.
2
Chimeric Glutamate Receptor Subunits Reveal the Transmembrane Domain Is Sufficient for NMDA Receptor Pore Properties but Some Positive Allosteric Modulators Require Additional Domains.嵌合型谷氨酸受体亚基揭示跨膜结构域足以决定NMDA受体的孔道特性,但某些正性变构调节剂需要其他结构域。
J Neurosci. 2016 Aug 24;36(34):8815-25. doi: 10.1523/JNEUROSCI.0345-16.2016.
3
Mechanism and properties of positive allosteric modulation of N-methyl-d-aspartate receptors by 6-alkyl 2-naphthoic acid derivatives.6-烷基-2-萘甲酸衍生物对 N-甲基-D-天冬氨酸受体的正变构调节的机制和性质。
Neuropharmacology. 2017 Oct;125:64-79. doi: 10.1016/j.neuropharm.2017.07.007. Epub 2017 Jul 11.
4
A Molecular Determinant of Subtype-Specific Desensitization in Ionotropic Glutamate Receptors.离子型谷氨酸受体亚型特异性脱敏的分子决定因素
J Neurosci. 2016 Mar 2;36(9):2617-22. doi: 10.1523/JNEUROSCI.2667-15.2016.
5
Contribution of the M1 transmembrane helix and pre-M1 region to positive allosteric modulation and gating of N-methyl-D-aspartate receptors.M1 跨膜螺旋和前 M1 区对 N-甲基-D-天冬氨酸受体正变构调节和门控的贡献。
Mol Pharmacol. 2013 May;83(5):1045-56. doi: 10.1124/mol.113.085209. Epub 2013 Mar 1.
6
The Negative Allosteric Modulator EU1794-4 Reduces Single-Channel Conductance and Ca Permeability of GluN1/GluN2A -Methyl-d-Aspartate Receptors.负变构调节剂 EU1794-4 降低 GluN1/GluN2A-甲基-d-天冬氨酸受体的单通道电导和钙通透性。
Mol Pharmacol. 2021 May;99(5):399-411. doi: 10.1124/molpharm.120.000218. Epub 2021 Mar 9.
7
Arrangement of subunits in functional NMDA receptors.功能性 NMDA 受体亚基的排列。
J Neurosci. 2011 Aug 3;31(31):11295-304. doi: 10.1523/JNEUROSCI.5612-10.2011.
8
Structure-based discovery of antagonists for GluN3-containing N-methyl-D-aspartate receptors.基于结构的含 GluN3 的 N-甲基-D-天冬氨酸受体拮抗剂的发现
Neuropharmacology. 2013 Dec;75:324-36. doi: 10.1016/j.neuropharm.2013.08.003. Epub 2013 Aug 22.
9
Negative allosteric modulation of GluN1/GluN3 NMDA receptors.谷氨酸 N-甲基-D-天冬氨酸受体 GluN1/GluN3 的负变构调节。
Neuropharmacology. 2020 Oct 1;176:108117. doi: 10.1016/j.neuropharm.2020.108117. Epub 2020 May 7.
10
Molecular mechanism of ligand gating and opening of NMDA receptor.NMDA 受体配体门控和开放的分子机制。
Nature. 2024 Aug;632(8023):209-217. doi: 10.1038/s41586-024-07742-0. Epub 2024 Jul 31.

引用本文的文献

1
Discovery of novel GluN1/GluN3A NMDA receptor inhibitors using a deep learning-based method.使用基于深度学习的方法发现新型GluN1/GluN3A N-甲基-D-天冬氨酸受体抑制剂。
Acta Pharmacol Sin. 2025 May 12. doi: 10.1038/s41401-025-01571-1.
2
Bi-directional allosteric pathway in NMDA receptor activation and modulation.NMDA 受体激活和调节的双相变构途径。
Nat Commun. 2024 Oct 13;15(1):8841. doi: 10.1038/s41467-024-53181-w.
3
Discovery of GluN2A subtype-selective -methyl-d-aspartate (NMDA) receptor ligands.谷氨酸N2A亚型选择性 - 甲基 - D - 天冬氨酸(NMDA)受体配体的发现。
Acta Pharm Sin B. 2024 May;14(5):1987-2005. doi: 10.1016/j.apsb.2024.01.004. Epub 2024 Jan 10.
4
Therapeutic potential of N-methyl-D-aspartate receptor modulators in psychiatry.N-甲基-D-天冬氨酸受体调节剂在精神病学中的治疗潜力。
Neuropsychopharmacology. 2024 Jan;49(1):51-66. doi: 10.1038/s41386-023-01614-3. Epub 2023 Jun 27.
5
Novel neuroactive steroids as positive allosteric modulators of NMDA receptors: mechanism, site of action, and rescue pharmacology on GRIN variants associated with neurological conditions.新型神经活性甾体作为 NMDA 受体的正变构调节剂:与神经疾病相关的 GRIN 变体的作用机制、作用部位和挽救药理学。
Cell Mol Life Sci. 2023 Jan 16;80(2):42. doi: 10.1007/s00018-022-04667-7.
6
The positive allosteric modulator of NMDA receptors, GNE-9278, blocks the ethanol-induced decrease of excitability in developing retrosplenial cortex neurons from mice.N-甲基-D-天冬氨酸受体的正变构调节剂 GNE-9278 可阻断乙醇诱导的来自小鼠的后隔核皮质神经元兴奋性降低。
Neuropsychopharmacol Rep. 2023 Mar;43(1):77-84. doi: 10.1002/npr2.12306. Epub 2022 Dec 15.
7
Structure, Function, and Pharmacology of Glutamate Receptor Ion Channels.谷氨酸受体离子通道的结构、功能和药理学。
Pharmacol Rev. 2021 Oct;73(4):298-487. doi: 10.1124/pharmrev.120.000131.
8
Three-dimensional missense tolerance ratio analysis.三维错义容忍比分析。
Genome Res. 2021 Aug;31(8):1447-1461. doi: 10.1101/gr.275528.121. Epub 2021 Jul 22.
9
Discovery of Dihydropyrrolo[1,2-]pyrazin-3(4)-one-Based Second-Generation GluN2C- and GluN2D-Selective Positive Allosteric Modulators (PAMs) of the -Methyl-d-Aspartate (NMDA) Receptor.发现基于二氢吡咯并[1,2-]吡嗪-3(4)-酮的第二代 NMDA 受体甘氨酸结合位点别构调节剂(PAMs),对 GluN2C 和 GluN2D 具有选择性。
J Med Chem. 2020 Jul 23;63(14):7569-7600. doi: 10.1021/acs.jmedchem.9b01733. Epub 2020 Jul 6.
10
Hodgkin-Huxley-Katz Prize Lecture: Genetic and pharmacological control of glutamate receptor channel through a highly conserved gating motif.霍奇金-赫胥黎-卡茨奖演讲:通过高度保守的门控基序对谷氨酸受体通道进行遗传和药理学控制。
J Physiol. 2020 Aug;598(15):3071-3083. doi: 10.1113/JP278086. Epub 2020 Jun 15.